Correction: PARP1 inhibitor combined with oxaliplatin efficiently suppresses oxaliplatin resistance in gastric cancer-derived organoids via homologous recombination and the base excision repair pathway - Li, Huafu; Wang, Chunming; Lan, Linxiang; Wu, Wenhui; Evans, Ian; Ruiz, E. Josue; Yan, Leping; Zhou, Zhijun; Oliveira, Joaquim M.; Reis, Rui L.; Hu, Zhenran; Chen, Wei; et al. (Frontiers in Cell and Developmental Biology, 2025)